Stanisic, S., A. Bertolotto, P. Berto, P. Di Procolo, and J. Morawski. “The Cost-Effectiveness of Alemtuzumab in the Management of Relapse-Remitting Multiple Sclerosis in Italy”. Global and Regional Health Technology Assessment, vol. 6, no. 1, Apr. 2019, doi:10.33393/grhta.2019.465.